Mc Services News Today

EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Miscellaneous QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class

EQS-News: QUANTRO Therapeutics GmbH / Key word(s): MiscellaneousQUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments 04.06.2024 / 23:07 CET/CESTThe issuer is solely responsible for the content of this announcement.QUANTRO Therapeutics rea...

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ...

EQS-News: Heidelberg Pharma AG / Key word: Conference Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024...

JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...

EQS-News: Heidelberg Pharma AG / Key word: Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 25.04.2024 /...

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including...

Issuer: Mainz BioMed N.V. / Key word(s): Study results25.04.2024 / 15:29 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Cli...

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including previously unexamined and reported patients

·         With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide·        ...